生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | T0070907 is a potent and selective PPARγ antagonist with Ki value of 1nM, with >800-fold preference for PPARγ over PPARα and PPARδ with Ki values of 0.85μM and 1.8 μM. T0070907 at concentration ranging in 1nM-1μM dose-dependently antagonized the effects of rosiglitazone at concentration 1μM in HTRF assays, blocking agonist-induced recruitment of coactivator-derived peptides to PPARγ. It promoted recruitment of the transcriptional corepressor NCoR to PPARγ/RXR heterodimer[1]. Treatment with 50μM T0070907 for 24h led loss of 70% cell adherence in trypsinized HepG2 cells, associated with reductions in phosphorylated FAK[2]. | ||
作用机制 | T0070907 covalently modifies PPARγ on cysteine 313 in helix 3 of human PPARγ2. T0070907 modulates the interaction of PPARγ with cofactor proteins by affecting the conformation of helix 12 of the PPARγ ligand-binding domain.[1] |
细胞研究 | |||||
---|---|---|---|---|---|
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
african green monkey OR6 cells | Cytotoxic assay | Cytotoxicity against african green monkey OR6 cells after 72 hrs by WST1 assay, CC50=2.7 μM | 23891183 |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.60mL 0.72mL 0.36mL |
18.01mL 3.60mL 1.80mL |
36.01mL 7.20mL 3.60mL |
参考文献 |
---|